SMMT 8-K 2026-09-28

Summit Therapeutics Inc. (SMMT) 8-K dated 2026-09-28 — accession 0001193125-26-405776. This URL is the filing, not the SMMT hub.

Summit Therapeutics Inc. (SMMT) is a biotechnology company listed on US.

Summit Therapeutics Inc. filed a 8-K on 2026-09-28. Accession 0001193125-26-405776.

Cached items: 1.01, 3.02, 5.03, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported SMMT revenue for 2024-12-31 was $0. Net income was -$221.3M. SMMT currently screens at market cap $11.46B.

Not investment advice. The SMMT SEC hub lists recent forms. The stock page is the research view.